Type 2 diabetes mellitus associated with increased risk for colorectal cancer: Evidence from an international ecological study and population-based risk analysis in China

Public Health

Volumn 123, Issue 8, 2009, Pages 540-544

  Ren, X ^a   Zhang, X ^a,a,b   Gu, W ^c   Chen, K ^a   Le, Y ^a   Lai, M ^a   Zhu, Y ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hangzhou Centers of Disease Prevention and Control   (China)

^c Jiaxing Centers of Disease Prevention and Control   (China)

Author keywords

Colorectal cancer; Ecological study; Standardized incidence ratio; Type 2 diabetes mellitus

Indexed keywords

CANCER; CORRELATION; DIABETES; DISEASE INCIDENCE; DISEASE PREVALENCE; RISK ASSESSMENT;

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHINA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

CHINA; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; RISK; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

ASIA; CHINA; EURASIA; FAR EAST;

EID: 69649105244     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2009.06.019     Document Type: Article

References (40)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Chen K., Lindsey J.B., Khera A., De Lemos J.A., Ayers C.R., Goyal A., et al. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study. Diab Vasc Dis Res 5 (2008) 96-101
3. Metcalf P.A., Wells S., Scragg R.K., and Jackson R. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with type 2 diabetes mellitus. N Z Med J 121 (2008) 49-57
4. Schindler T.H., Facta A.D., Prior J.O., Cadenas J., Zhang X.L., Li Y., et al. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging (2008)
5. Fox C.S., and Muntner P. Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988-1994 to 1999-2004. Diabetes Care 31 (2008) 1337-1342
6. Engelgau M.M., Geiss L.S., Saaddine J.B., Boyle J.P., Benjamin S.M., Gregg E.W., et al. The evolving diabetes burden in the United States. Ann Intern Med 140 (2004) 945-950
7. Tran T.T., Gupta N., Goh T., Naigamwalla D., Chia M.C., Koohestani N., et al. Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. Cancer Epidemiol Biomarkers Prev 12 (2002) 47-56
8. Tran T.T., Medline A., and Bruce W.R. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5 (1996) 1013-1015
9. Shao L., Huang Q., Luo M., and Lai M. Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocr Relat Cancer 11 (2004) 141-148
10. Kaaks R., Toniolo P., Akhmedkhanov A., Lukanova A., Biessy C., Dechaud H., et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92 (2000) 1592-1600
11. Palmqvist R., Stattin P., Rinaldi S., Biessy C., Stenling R., Riboli E., et al. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden. Int J Cancer 107 (2003) 89-93
12. Larsson S.C., Orsini N., and Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97 (2005) 1679-1687
13. Oba S., Nagata C., Nakamura K., Takatsuka N., and Shimizu H. Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. J Epidemiol 18 (2008) 197-203
14. Larsson S.C., Mantzoros C.S., and Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121 (2007) 856-862
15. Larsson S.C., Orsini N., Brismar K., and Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49 (2006) 2819-2823
16. Pierce B.L., Plymate S., Ostrander E.A., and Stanford J.L. Diabetes mellitus and prostate cancer risk. Prostate 68 (2008) 1126-1132
17. Rubenstein J.H., Davis J., Marrero J.A., and Inadomi J.M. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia. Aliment Pharmacol Ther 22 (2005) 267-271
18. Smith M.R., Bae K., Efstathiou J.A., Hanks G.E., Pilepich M.V., Sandler H.M., et al. Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. J Clin Oncol 26 (2008) 4333-4339
19. Torisu Y., Ikeda K., Kobayashi M., Hosaka T., Sezaki H., Akuta N., et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res 37 (2007) 517-523
20. Limburg P.J., Anderson K.E., Johnson T.W., Jacobs Jr. D.R., Lazovich D., Hong C.P., et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 14 (2005) 133-137
21. Hu F.B., Manson J.E., Liu S., Hunter D., Colditz G.A., Michels K.B., et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91 (1999) 542-547
22. Weiderpass E., Ye W., Vainio H., Kaaks R., and Adami H.O. Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102 (2002) 258-261
23. Pan X.R., Yang W.Y., Li G.W., and Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20 (1997) 1664-1669
24. Aspray T.J., Mugusi F., Rashid S., Whiting D., Edwards R., Alberti K.G., et al. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg 94 (2000) 637-644
25. Jin T. Why diabetes patients are more prone to the development of colon cancer?. Med Hypotheses 71 (2008) 241-244
26. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva
27. Yang Y.X., Hennessy S., and Lewis J.D. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 3 (2005) 587-594
28. Brauer P.M., McKeown-Eyssen G.E., Jazmaji V., Logan A.G., Andrews D.F., Jenkins D., et al. Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia. Am J Epidemiol 156 (2002) 702-713
29. Elwing J.E., Gao F., Davidson N.O., and Early D.S. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol 101 (2006) 1866-1871
30. Limburg P.J., Vierkant R.A., Fredericksen Z.S., Leibson C.L., Rizza R.A., Gupta A.K., et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 101 (2006) 1872-1879
31. Seow A., Yuan J.M., Koh W.P., Lee H.P., and Yu M.C. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 98 (2006) 135-138
32. Weiderpass E., Gridley G., Nyren O., Ekbom A., Persson I., and Adami H.O. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 89 (1997) 660-661
33. Harris M.I., and Eastman R.C. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 16 (2000) 230-236
34. Bufill J.A. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113 (1990) 779-788
35. Distler P., and Holt P.R. Are right- and left-sided colon neoplasms distinct tumors?. Dig Dis 15 (1997) 302-311
36. Schoen R.E., Weissfeld J.L., Kuller L.H., Thaete F.L., Evans R.W., Hayes R.B., et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 129 (2005) 464-475
37. Sandhu M.S., Dunger D.B., and Giovannucci E.L. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94 (2002) 972-980
38. Wu X., Zhao H., Do K.A., Johnson M.M., Dong Q., Hong W.K., et al. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res 10 (2004) 3988-3995
39. Yu H., Spitz M.R., Mistry J., Gu J., Hong W.K., and Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91 (1999) 151-156
40. Landman G.W., Ubink-Veltmaat L.J., Kleefstra N., Kollen B.J., and Bilo H.J. Increased cancer mortality in type 2 diabetes (ZODIAC-3). Anticancer Res 28 (2008) 1373-1375